MAL21106134TCTraditional Herbal (MAL-T)

BFI Breazco Capsule

Generic Molecule: Lignosus Rhinocerus

ACTIVE & APPROVEDValid till: 27 Oct 2026
NPRA Official Regulatory Summary

BFI Breazco Capsule is a KKM-approved Traditional & Herbal registered under MAL number MAL21106134TC by BF INTERNATIONAL SDN. BHD.. Its active ingredient is Lignosus rhinocerus 200 mg 447 mg, Undaria pinnatifida 45 mg 447 mg, Hedera helix 50 mg 447 mg, Eucalyptus globulus 100 mg 447 mg, manufactured by GANOFARM R&D SDN BHD.

Holder (PRH)
BF INTERNATIONAL SDN. BHD.
Manufacturer
GANOFARM R&D SDN BHD
First Registered
27 Oct 2021
Validity
27 Oct 2026

Check Verified Pharmacy Stock & Best Price

Compare retail prices across licensed Malaysian pharmacies (Watsons, Guardian, Big Pharmacy, Shopee Mall).

Active Ingredients & Strength Formulation

4 Components
Active Substance / MoleculeDeclared Strength / DosageGeneric Directory
Lignosus rhinocerus200 mg 447 mgFind Brands
Undaria pinnatifida45 mg 447 mgFind Brands
Hedera helix50 mg 447 mgFind Brands
Eucalyptus globulus100 mg 447 mgFind Brands
Dosage values indicate declared active concentration per unit dose as registered with NPRA Malaysia.

Malaysian KKM Security Hologram Verification

FarmaChecker & Meditag™

By Malaysian Ministry of Health (KKM) regulation, all genuine registered pharmaceuticals, health supplements (MAL-N), and traditional products (MAL-T) distributed in Malaysia must feature an official tamper-evident security hologram sticker on the physical packaging.

1. Visual Tilt Check

Tilt the box under light to view the micro-engraved KKM coat of arms and multi-layer iridescent security patterns.

2. Match MAL Number

Ensure the printed MAL code matches MAL21106134TC exactly on label and box.

3. FarmaChecker Scan

Scan using the official FarmaChecker app on iOS / Android to authenticate serial token with NPRA servers.

If the packaging lacks a security hologram or fails the FarmaChecker scan, do not consume and report to Cawangan Penguatkuasaan Farmasi (CPF KKM).
Frequently Asked Questions & Verification Details

Is BFI Breazco Capsule approved by KKM / NPRA?

Yes. BFI Breazco Capsule is actively registered with the National Pharmaceutical Regulatory Agency under official registration number MAL21106134TC with current status PRODUCT APPROVED. Registration was filed by BF INTERNATIONAL SDN. BHD..

What are the active ingredients of BFI Breazco Capsule?

The declared active therapeutic components are: Lignosus rhinocerus 200 mg 447 mg, Undaria pinnatifida 45 mg 447 mg, Hedera helix 50 mg 447 mg, Eucalyptus globulus 100 mg 447 mg. Always follow dosage recommendations prescribed by a certified doctor or licensed pharmacist.

What are the registered generic alternatives in Malaysia?

In Malaysia, there are 123 registered brand formulations containing identical active ingredients (Lignosus Rhinocerus). You can review them in the alternative brands section above or consult your community pharmacist for generic bioequivalent substitution.

Semakan status pendaftaran KKM / NPRA: BFI Breazco Capsule (MAL21106134TC) | Pengganti ubat di Malaysia | Bahan aktif ubat & maklumat farmasi.